Venture Life Share Discussion Threads

[hydrus] 20/7/2017 08:55

Still hold (smallish amount) as not quite ready to fully let go lol

[apad] 20/7/2017 08:34

Indeed, MJ. Pity they don't do Jersey companies.

IAB interface is driving me nuts.

IG helpful and straightforward so far.

apad

[apad] 20/7/2017 08:30

Surprised that the BREE price isn't stronger, red.
apad

[melton john] 20/7/2017 08:23

Superb results for JIM

[redartbmud] 20/7/2017 07:58

APAD

Bree might have been a better selection as the sector pick in my choice for the competition.
Maybe next time that sector can be excluded in the interests of my sanity (and pocket)
Just joking :-)

Follow the man. Tom did it successfully at Bardon and sold out. Repeating the exercise, successfully, at Breedon.
Follow the man, Follow the man.


Rpc has perked up. Looks like Mr Market got that one wrong.
I know it is a parallel universe to most of the picks on the board. Still more to go in the medium term.

red

[apad] 20/7/2017 07:50

BREE looks v. impressive and Bunzl still buying companies.
Happy days, red.
apad

[modform] 20/7/2017 07:19

IQE, looks like a very positive statement, semiconductors are on a roll, they are almost back to all time high after GS downgraded them a few weeks ago.In a bull market, semiconductors lead followed by technology companies.

[lauders] 20/7/2017 01:50

Oh eck! No miners or oil/gas in the next comp? Will have to alter my holdings a bit then as won't be much to enter next time ;-)

[redartbmud] 19/7/2017 21:16

Out all day, since 8.15am. Back now lots to catch up on.

APAD

Trading a few shares does work in the context of reducing the running cost of a share. The downside is slow and tedious.

Big7
Now that you have cracked the random lines on the page, any suggestions would be gratefully received :-)

Piedro seems to be spot on with his comment on the Tstl dividend policy. It could have been better worded, but we are in the modern world.
Aside BBC Breakfast TV presenter said Roger Federer was going for 8 titles in the Wimbledon Men's Final! Worth a salary of £250k per annum!! In fact, she must be worthy of promotion to an even higher paid job.

red

[melton john] 19/7/2017 21:01

BTW Pete, Jarvis Securities site says confirmed date for interims(and presumably divi) announcements is tomorrow

[petersinthemarket] 19/7/2017 20:51

Mny Tks MJ - And perhaps this extract partly answers the dividend query:

''For the past two financial years, we have returned surplus cash to our shareholders via the payment of a special dividend – 3 pence per share in August 2015, and another 3p in August 2016. We are not making a similar announcement today because your Board is considering the company’s dividend policy in view of these excellent results and the continuing cash generation of the business, whilst at the same time factoring in our expansion into North America. However, I can assure you that the current policy of two times cover will be maintained at the very least.''
pete

[melton john] 19/7/2017 20:14

I haven't seen this posted yet.

[hydrus] 19/7/2017 19:40

Peter summer so far has been very good for me also. Maybe it will be sell in July this year though? Who knows. Growth companies (quality ones) are powering ahead.

[petersinthemarket] 19/7/2017 19:32

Am I being optimistic (or just lucky)? Has the 'Sell in May' idea crashed into legend? Despite my 'early summer' gloom my pf is after all not doing too badly at all. Certainly better than had I ditched it all in the Spring for Autumn buyback. And Mrs P's pf is also going very strongly in the last couple of months, in fact more strongly in percentage terms than mine, partly due to the Total Return side of investing for dividends. Pete

[petersinthemarket] 19/7/2017 19:26

#12440 100% agreed A - plus or minus, they distort the outcomes - I suspect we have been down the 'exclude' road once before but for my two pennyworth I would suggest leaving out all mining and exploration companies of any kind (liars and optimists at the top of a hole in the ground), and all early day pharma drug companies (might save the world merchants), and all companies collecting patents in the hope of future breakthroughs (hope to find a use for it in due course). pete

[apad] 19/7/2017 19:14

Competition
Fozzie has leapt into the lead because of UKOG (say a penny to fourpence).
I think we should exclude oil explorers from any future competition.
apad

[janeann] 19/7/2017 19:05

Hadnt seen the comments re tstl and antibiotic resistance; even if new antibiotics are developed (especially new classes of compound with new modes of action - which is what is really needed) which isn't likely in the short term, any alternative broad spectrum biocide has to have a huge place in resistance management to maintain the longevity of usefulness of existing compounds. Resistance is always going to develop - but far less likely to broad spectrum multi site compounds like chlorine. (There is the same problem in weed control in agriculture - hence more ploughing because folk cant now control blackgrass with chemicals).

ps I hold.

[return_of_the_apeman] 19/7/2017 18:08

Evening

Not seen CAML mentioned on this thread before, seems to tick enough of the boxes below to me so have bought some

1. Earnings growth, ideally over several years
2. Good margins / strong profitablility
3. Preferably no debt, although modest gearing can be acceptable
4. Modest p/e ratio, say between 3 and 15 (perhaps up to 25 if the opportunity is exceptional)
5. Ideally being traded at a discount to NAV, although a low ratio can also be acceptable
6. Good management
7. Pays a dividend
8. Deep "Moat" (defendable market position)

[apad] 19/7/2017 18:03

ps
I see GSK's new boss is stirring things up.

[apad] 19/7/2017 18:02

Just noticed the S&P500 - no stoppin' them yoodles!
apad

[apad] 19/7/2017 17:53

Interesting debate on TSTL.
My own view is that it is not an either/or issue.
Governments might fund antibiotic research, but whether or no there will be a need for TSTL's cleaning technology.
apad

[apad] 19/7/2017 17:50

The excellent rivaldo found this:

"PTSG on hand for Morgan Sindall

Premier Technical Services Group PLC (PTSG) has successfully completed a large maintenance project for Morgan Sindall over just one weekend.

Morgan Sindall is a British-based construction services business headquartered in London. It was founded in 1977, and has since grown to employ around 6,000 people across its six divisions.

PTSG’s wet and dry riser maintenance division was brought in by the construction company to test 18 sites in its portfolio. This work required a quick turnaround, and the Group’s maintenance teams were able to complete all tests and inspections by the end of the very next day.

The tests carried out at these sites ensure that each building is safe and compliant, and that its fire safety systems are always able to operate at their full capacity.

PTSG is the leading specialist installer of wet and dry riser systems in the UK and this maintenance service forms part of its broad package of fire safety services. The Group’s wet and dry riser engineers have worked on a wide range of projects throughout the country, including prestigious contracts at the Olympic Park and Anfield Stadium."

[melton john] 19/7/2017 17:38

Do you mean new antibiotics have not been developed? I think this extract covers what you are saying.

"So why not just develop new antibiotics that the bacteria can’t resist? It has been several decades since a drug company developed and sold a new antibiotic. “You would like to have new antibiotics to treat infections with resistant bacteria, but if you look at the timeline [of new releases] it is empty for almost 30 years,” Sprenger says.

That’s because the process of developing any new drug is extremely expensive and the potential profit in an antibiotic after that massive investment is relatively low. According to Sprenger, “there are no legal instruments to prohibit the use of a new antibiotic.” What that means is if a new antibiotic is released there’s no way to stop the world from overusing it. At current usage levels a new antibiotic, he says, would only have about two years on the market before bacterial resistance to it develops."

I think you are over optimistic if you think pharma companies are just waiting for demand to rise and for people to pay up or die. Search anti-biotic resistance and the opinions are heavily towards a post-antibiotic era.